Develop and maintain strong relationships with KOLs, healthcare professionals, and academic institutions
Communicate clinical and scientific data to KOLs and healthcare professionals
Support the synthesis and communicate scientific insights from KOLs
Provide scientific support for medical congresses and advisory boards
Establish credibility as a scientific expert for internal stakeholders
Collaborate cross-functionally with medical affairs, clinical development, and marketing
Stay current with scientific literature and competitive landscape
Networking
Showing 1 of 6 positions
About Revolution Medicines
Revolution Medicines pioneers new cancer therapies by reconfiguring natural substances into best-in-class medicines. You will join an oncology company developing novel targeted therapies for patients with RAS-addicted cancers. Their innovative approach transforms simple chemical building blocks into optimized drug candidates. This work serves a critical need, addressing cancers driven by mutations in the RAS signaling pathway, like lung, pancreatic, and colorectal cancers. They are a late-stage clinical oncology company, meaning you will contribute to therapies nearing patient impact.
How We Work
Revolution Medicines fosters a collaborative environment where passionate professionals unite against cancer. Your colleagues are experts in biology, chemistry, pharmacology, and clinical science, all dedicated to a shared mission. They support a globally distributed work culture, with many positions explicitly offered as remote within the United States. This flexibility allows you to contribute from where you thrive best, making an impact regardless of your physical location. Expect a supportive atmosphere focused on achieving significant scientific breakthroughs together.
Science & Innovation at Revolution Medicines
Revolution Medicines’ scientific foundation builds on a transformative method for synthesizing original compounds. This rapid, standardized process assembles simple chemical building blocks into refined natural product-like structures. They utilize a proprietary tri-complex inhibitor platform to target the active state of RAS proteins, offering a novel approach to cancer treatment. This unique technology enables the development of RAS(ON) inhibitors designed to suppress diverse oncogenic RAS variants. You will work with cutting-edge science, including the use of state-of-the-art quantitative modeling, to guide clinical development.
Why Join Us
Drive direct patient impact, developing therapies for RAS-addicted cancers, including lung, pancreatic, and colorectal.
Contribute to a company with a strong financial foundation, including $2 billion in flexible funding from Royalty Pharma.
Work in a collaborative, supportive environment with colleagues united by a clear mission.
Engage with innovative science, utilizing a proprietary tri-complex inhibitor platform and advanced modeling techniques.
Benefit from robust total rewards, including competitive compensation, equity awards, and strong health benefits.
Benefits & Perks
401(K) retirement plan.
Generous parental leave.
Comprehensive health insurance (medical, dental, vision).
Flexible Spending Accounts (FSA) and Health Savings Accounts (HSA) with company contributions.
Virtual care with $0 copay for PPO Plan enrollees.
Support for specialty medications through Accredo, potentially reducing costs.